Anzeige
Mehr »
Freitag, 20.06.2025 - Börsentäglich über 12.000 News
+435 % Beteiligungsrendite durch TAO nach £5 Mio. Finanzierung und Bitcoin-Treasury-Strategie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PHH8 | ISIN: IT0005366601 | Ticker-Symbol: 2YK
Frankfurt
20.06.25 | 08:06
4,190 Euro
-1,64 % -0,070
1-Jahres-Chart
ANTARES VISION SPA Chart 1 Jahr
5-Tage-Chart
ANTARES VISION SPA 5-Tage-Chart
RealtimeGeldBriefZeit
4,2954,31014:58
4,2954,31014:52
PR Newswire
253 Leser
Artikel bewerten:
(1)

GUINEA-BISSAU LOOKS TO THE FUTURE OF PUBLIC HEALTH: HEALTH MINISTER PEDRO TIPOTE VISITS ANTARES VISION GROUP TO STRENGTHEN COOPERATION IN HEALTHCARE DIGITALIZATION

BRESCIA, Italy, May 26, 2025 /PRNewswire/ -- At a time when secure and traceable access to medicine is increasingly essential to public well-being, the Republic of Guinea-Bissau is advancing its journey toward a deep digital transformation of its national healthcare system. Underscoring this commitment was the official visit to Antares Vision Group headquarters by PublicHealth Minister Engr. Pedro Tipote, aimed at strengthening the strategic partnership initiated with the agreement signed last February. The shared goal is ambitious and forward-looking: to build a fully digitalized healthcare ecosystem that ensures transparency and traceability across the entire pharmaceutical supply chain.

The Public Health Minister of Guinea-Bissau visits Antares Vision Group

This project goes beyond pharmaceutical safety: it aims to set a new benchmark for healthcare innovation across West Africa. At the heart of the collaboration is the implementation of the country's first national system for drug verification and traceability, powered by advanced technologies from Antares Vision Group. Indeed, using the rfxcel Traceability Hub (rTH) and rfxcel Government (rGOV) platforms, registration of all supply chain stakeholders will become mandatory during 2025. This will allow for drug authentication at every step, real-time access to reliable data for regulatory authorities, and clear, digital information for citizens.

The visit also served as a platform to discuss expanding the collaboration to include the creation of a national pharmaceutical manufacturing facility, initially focused on essential medicines, a strategic move not only for Guinea-Bissau but for neighboring countries within the Economic Community of West African States (ECOWAS). Enhancing pharmaceutical logistics was also discussed, with digital solutions for the central warehouse and regional distribution to ensure nationwide continuity and security.

"With this initiative, Guinea-Bissau aims to position itself as a potential leader in digital health, promoting a model grounded in reliable data, secure supply chains, and active citizen engagement," added Engr. Pedro Tipote, PublicHealth Minister of Guinea-Bissau.

"Pharmaceutical safety is not just about technology, it's a fundamental pillar of the right to health," said Gianluca Mazzantini, CEO of Antares Vision Group. "That's why we are honored to support Guinea-Bissau by sharing our expertise to help create a modern, transparent, and sustainable healthcare system, one that can serve as a model for other Countries in the Region."

Antares Vision Group stands by the country on this path, with an approach that blends global expertise and local commitment, from skills development and institutional partnerships to the creation of innovation hubs and digital infrastructure supporting national systems.

ABOUT ANTARES VISION GROUP

Antares Vision Group is the Italian multinational company that ensures product safety and supply chain transparency thanks to innovative technologies for quality control (inspection systems and machines), end-to-end traceability (serialization and aggregation solutions) and integrated data management (powered by artificial intelligence and integrated with blockchain). This is possible through DIAMIND, the integrated, modular ecosystem of solutions that guides the path toward digital transformation of companies, products and supply chains, to improve security and transparency in supply chains. www.antaresvisiongroup.com

Photo - https://mma.prnewswire.com/media/2695376/VISITA_MINISTRO_GUINEA_BISSAU.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/guinea-bissau-looks-to-the-future-of-public-health-health-minister-pedro-tipote-visits-antares-vision-group-to-strengthen-cooperation-in-healthcare-digitalization-302465102.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.